This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Journal of Acquired Immune Deficiency Syndromes | |
|---|---|
| Title | Journal of Acquired Immune Deficiency Syndromes |
| Discipline | Infectious disease |
| Abbreviation | J. Acquir. Immune Defic. Syndr. |
| Publisher | Lippincott Williams & Wilkins |
| Country | United States |
| History | 1988–present |
| Frequency | Monthly |
| Impact | 3.5 |
| Impact-year | 2023 |
| Issn | 1525-4135 |
Journal of Acquired Immune Deficiency Syndromes is a peer-reviewed medical journal focusing on HIV/AIDS research, clinical practice, and public health policy. The journal publishes original research, reviews, guidelines, and commentaries that intersect with topics addressed by World Health Organization, Centers for Disease Control and Prevention, and institutions such as Johns Hopkins University, Harvard Medical School, and University of California, San Francisco. It serves researchers, clinicians, and policymakers engaged with organizations like UNAIDS, Bill & Melinda Gates Foundation, and National Institutes of Health.
The journal was established in 1988 amid the global response to the HIV/AIDS epidemic contemporaneous with activities by Terrence Higgins Trust, Act Up, and initiatives from European Commission funding streams. Early editors included leaders affiliated with Rockefeller University and National Institute of Allergy and Infectious Diseases, and the publication has tracked milestones such as the introduction of zidovudine, the development of highly active antiretroviral therapy, and policy shifts influenced by PEPFAR and Global Fund to Fight AIDS, Tuberculosis and Malaria. Over decades the journal has mirrored scientific debates present at forums like the International AIDS Conference and collaborations involving Médecins Sans Frontières.
The journal covers basic science topics connected to Yale University and Massachusetts General Hospital laboratories, clinical trials coordinated with groups such as INSIGHT and ACTG, epidemiology consistent with surveillance by Public Health England and European Centre for Disease Prevention and Control, and implementation research relevant to Clinton Health Access Initiative. Content spans virology reports linked to research from Pasteur Institute and Fred Hutchinson Cancer Research Center, immunology studies related to work at Scripps Research, pharmacology analyses involving collaborations with GlaxoSmithKline and Merck & Co., and health systems research referencing World Bank program evaluations. Reviews synthesize findings from investigators at Karolinska Institutet, University of Cape Town, and University of São Paulo.
Published monthly by Lippincott Williams & Wilkins, the journal operates an editorial office with editors drawn from institutions such as Columbia University, Imperial College London, and University of Michigan. The peer-review process engages reviewers affiliated with University of Oxford, Stanford University, University of Toronto, and professional societies like the Infectious Diseases Society of America and International AIDS Society. The journal has issued special editorial statements in coordination with agencies including UNAIDS and the World Health Organization Emergency Response Framework.
The journal is indexed in databases operated by Clarivate, Elsevier, and National Library of Medicine, and is included in abstracting services associated with PubMed, Scopus, and Web of Science. Its metadata is used by repositories connected to CrossRef, library networks such as OCLC, and platforms partnering with HighWire Press and Springer Nature services.
The journal’s impact factor, reported by Journal Citation Reports, reflects citations from authors at institutions including University of Amsterdam, University College London, and McGill University. Articles have informed policy deliberations by United Nations bodies and national programs in countries like South Africa, Brazil, and India. Scholarly reception has noted influence on clinical guidelines promulgated by American Academy of Pediatrics and treatment protocols adapted by Médecins Sans Frontières.
Notable publications include pivotal clinical trial reports drawing on data from collaborations with European Medicines Agency and network studies by International Maternal Pediatric Adolescent AIDS Clinical Trials Group. Special issues have focused on topics aligned with conferences such as the Conference on Retroviruses and Opportunistic Infections, thematic series on coinfections with Mycobacterium tuberculosis and Hepatitis C virus, and collections addressing maternal-child health with contributors from Bill & Melinda Gates Foundation initiatives and Clinton Health Access Initiative programs.
The journal is available in print and online through platforms maintained by Lippincott Williams & Wilkins, institutional subscriptions held by libraries at Harvard University, University of California campuses, and consortia such as HINARI. Individual articles may be accessed via institutional login, subscription, or pay-per-view, and select articles are made open access in partnership with funding agencies like Wellcome Trust and European Commission grant programs.
Category:Medical journals Category:HIV/AIDS